N'-(3'-monophospho-deoxyguanosin-8-yl)-N-acetylbenzidine formation by peroxidative metabolism

Carcinogenesis

Volumn 19, Issue 5, 1998, Pages 911-917

  Lakshmi, Vijaya M ^a   Zenser, Terry V ^a   Davis, Bernard B ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; ARACHIDONIC ACID; ASCORBIC ACID; BENZIDINE DERIVATIVE; CARCINOGEN; DEOXYGUANOSINE PHOSPHATE; DNA; GLUTATHIONE; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; INDOMETACIN; N' (3' MONOPHOSPHODEOXYGUANOSIN 8 YL) N ACETYLBENZIDINE; NUCLEASE; PHOSPHORUS 32; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ARTICLE; DNA ADDUCT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MICROSOME; PEROXIDATION; PRIORITY JOURNAL; SEMINAL VESICLE; SHEEP;

ANIMALS; BENZIDINES; BIOTRANSFORMATION; CARCINOGENS; DEOXYGUANOSINE; DNA ADDUCTS; MALE; MICE; MICROSOMES; PEROXIDES; SHEEP;

EID: 0031845641     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.5.911     Document Type: Article

References (62)

1. Case,R.A.M., Hosker,M.W., McDonald,D.B. and Pearson,J.T. (1954) Tumors of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Br. J. Ind. Med., 11, 75-104.
2. Doll,R. and Peto,R. (1981) The Causes of Cancer. Oxford University Press, New York.
3. Guerin,M.R. and Buchanan,M.V. (1988) Environmental exposure to N-aryl compounds. In King,C.M., Romano,L.J. and Schuetzle,D. (eds) Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes, Elsevier Science, New York, pp. 37-45.
4. Talaska,G., Schamer,M., Skipper,P. et al. (1991) Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: Association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol. Biomark. Prevent., 1, 61-66.
5. Beland,F.A. and Kadlubar,F.F. (1990) Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. In Cooper,C.S. and Grover,P.L. (eds) Handbook of Experimental Pharmacology. Springer-Verlag, Berlin, pp. 267-325.
6. Beland,F.A., Beranek,D.T, Dooley,K.L., Heflich,R.H. and Kadlubar,F.F. (1983) Arylamine-DNA adducts in vitro and in vivo: Their role in bacterial mutagenesis and urinary bladder carcinogenesis. Environ. Health Perspect., 49, 125-134.
7. Melchior,W.B.Jr, Marques,M.M. and Beland,F.A. (1994) Mutations induced by aromatic amine DNA adducts in pBR322. Carcinogenesis, 15, 889-899.
8. Heflich,R.H., Morris,S.M., Beranek,D.T., McGarrity,L.J., Chen,J.J. and Beland,F.A. (1986) Relationships between the DNA adducts and the mutations and sister-chromatid exchanges produced in Chinese hamster ovary cells by N-hydroxy-2-aminofluorene, N-hydroxy-N′-acetylbenzidine and 1-nitrosopyrene. Mutagenesis, 1, 201-206.
9. Lasko,D.D., Harvey,S.G., Malaikal,S.B., Kadlubar,F.F. and Essigmann,J.M. (1988) Specificity of mutagenesis by 4-aminobiphenyl. A possible role for N-(deoxyadenosin-8-yl)-4-aminobiphenyl as a premutational lesion. J. Biol. Chem., 263, 15429-15435.
10. Loechler,E.L. (1989) Adduct-induced base-shifts: A mechanism by which the adducts of bulky carcinogens might induce mutations. Biopolymers, 28, 909-927.
11. Fox,T.R., Schumann,A.M., Watanabe,P.G., Yano,B.L., Maher,V.M. and McCormick,J.J. (1990) Mutational analysis of the H-ras oncogene in spontaneous C57BL/6XC3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. Cancer Res., 50, 4014-4019.
12. Talaska,G., Au,W.W., Ward,J.J.B., Randerath,K. and Legator,M.S. (1987) The correlation between DNA adducts and chromosomal aberrations in the target organ of benzidine exposed, partially-hepatectomized mice. Carcinogenesis, 8, 1899-1905.
13. Zavon,M.R., Hoegg,U. and Bingham,E. (1973) Benzidine exposure as a cause of bladder tumors. Arch. Environ. Health, 27, 1-7.
14. Lakshmi,V.M., Bell,D.A., Watson,M.A., Zenser,T.V. and Davis,B.B. (1995) N-Acetylbenzidine and N,N′-diacetylbenzidine formation by rat and human liver slices exposed to benzidine. Carcinogenesis, 16, 1565-1571.
15. Frederick,C.B., Weis,C.C., Flammang,T.J., Martin,C.N. and Kadlubar,F.F. (1985) Hepatic N-oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the carcinogen, benzidine. Carcinogenesis, 6, 959-965.
16. Lakshmi,V.M., Zenser,T.V. and Davis,B.B. (1997) Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N′-diacetylbenzidine. Drug Metab. Dispos., 25, 481-488.
17. Martin,C.N., Beland,F.A., Roth,R.W. and Kadlubar,F.F. (1982) Covalent binding of benzidine and N-acetylbenzidine to DNA at the C-8 atom of deoxyguanosine in vivo and in vitro. Cancer Res., 42, 2678-2686.
18. Kennelly,J.C, Beland.F.A., Kadlubar,F.F. and Martin,C.N. (1984) Binding of N-acetylbenzidine and N,N′-diacetylbenzidine to hepatic DNA of rat and hamster in vivo and in vitro. Carcinogenesis, 5, 407-412.
19. Rothman,N., Bhatnagar,V.K., Hayes,R.B. et al. (1996) The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc. Natl Acad. Sci. USA, 93, 5084-5089.
20. Ohki,S., Ogino,N., Yamamoto,S. and Hayaishi,O. (1979) Prostaglandin hydroperoxidase, an integral part of prostaglandin endoperoxide synthetase from bovine vesicular gland microsomes. J. Biol. Chem., 254, 829-836.
21. Zenser,T.V., Mattammal,M.B. and Davis,B.B. (1979) Cooxidation of benzidine by renal medullary prostaglandin cyclooxygenase. J. Pharmacol. Exp. Ther., 211, 460-464.
22. Wise,R.W., Zenser,T.V., Kadlubar,F.F. and Davis,B.B. (1984) Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res., 44, 1893-1897.
23. Kadlubar,F.F., Frederick,C.B., Weis,C.C. and Zenser,T.V. (1982) Prostaglandin endoperoxide synthetase-mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein. Biochem. Biophys. Res. Commun., 108, 253-258.
24. Dunon,A., Zenser,T.V., Thomasson,D.L. and Davis,B.B. (1986) Eicosanoid synthesis by cultured human urothelial cells: Potential role in bladder cancer. Cancer Res., 46, 5676-5681.
25. Yamazoe,Y., Zenser,T.V. Miller,D.W. and Kadlubar,F.F. (1988) Mechanism of formation and structural characterization of DNA adducts derived from peroxidative activation of benzidine. Carcinogenesis, 9, 1635-1641.
26. Yamazoe,Y., Miller,D.W., Weis,C.C., Dooley,K.L., Zenser,T.V., Beland,F.A. and Kadlubar,F.F. (1985) DNA adducts formed by ring-oxidation of the carcinogen 2-naplithylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo. Carcinogenesis, 6, 1379-1387.
27. 32P-Postlabeling analysis of adducts generated by peroxidase-mediated binding of N-hydroxy-4-acetylaminobiphenyl to DNA. Carcinogenesis, 16, 2149-2157.
28. Josephy,P.D., Eling,T.E. and Mason,R.P. (1983) An electron spin resonance study of the activation of benzidine by peroxidases. Mol. Pharmacol. 23, 766-770.
29. Smith,B.J., DeBruin,L., Josephy,D. and Eling,T.E. (1992) Mutagenic activation of benzidine requires prior bacterial acetylation and subsequent conversion by prostaglandin H synthase to 4-nitro-4′-(acetylamino)-biphenyl. Chem. Res. Toxicol., 5, 431-439.
30. Hsu,F., Lakshmi,V., Rothman,N. et al. (1996) Determination of benzidine, N-acetylbenzidine and N,N′-diacetylbenzidine in human urine by capillary gas chromatography/negative ion chemical ionization mass spectrometry. Anal. Biochem., 234, 183-189.
31. Lakshmi,V.M., Mattammal,M.B., Spry,L.A., Kadlubar,F.F., Zenser,T.V. and Davis,B.B. (1990) Metabolism and disposition of benzidine in the dog. Carcinogenesis, 11, 139-144.
32. Lakshmi,V.M., Zenser,T.V., Goldman,H.D., Spencer,G.G., Gupta,R.C., Hsu,F.F. and Davis,B.B. (1995) The role of acetylation in benzidine metabolism and DNA adduct formation in dog and rat liver. Chem. Res. Toxicol., 8, 711-720.
33. Zenser,T.V., Mattammal,M.B. and Davis,B.B. (1978) Differential distribution of the mixed-function oxidase activities in rabbit kidney. J. Pharmacol. Exp. Ther., 207, 719-725.
34. Lakshmi,V.M., Mattammal,M.B., Zenser,T.V. and Davis,B.B. (1990) Mechanism of peroxidative activation of the bladder carcinogen 2-amino-4-(5-nitro-2-furyl)-thiazole (ANFT): comparison with benzidine. Carcinogenesis, 11, 1965-1970.
35. Lakshmi,V.M., Zenser,T.V. and Davis,B.B. (1994) Mechanism of 3-(glutathion-S-yl)-benzidine formation. Toxicol. Appl. Pharmacol., 125, 256-263.
36. 32P-Postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis, 3, 1081-1092.
37. 32P-postlabeling analysis of aromatic carcinogen-DNA adducts. Cancer Res., 45, 5656-5662.
38. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551.
39. Yamazoe,Y., Roth,R.W. and Kadlubar,F.F. (1986) Reactivity of benzidine diimine with DNA to form N-(deoxyguanosin-8-yl)-benzidine. Carcinogenesis, 7, 179-182.
40. Wise,R.W., Zenser,T.V. and Davis,B.B. (1983) Prostaglandin H synthase metabolism of the urinary bladder carcinogens benzidine and ANFT. Carcinogenesis, 4, 285-289.
41. Zenser,T.V., Mattammal,M.B., Wise,R.W., Rice,J.R. and Davis,B.B. (1983) Prostaglandin H synthase-catalyzed activation of benzidine: A model to assess pharmacologic intervention of the initiation of chemical carcinogenesis. J. Pharmacol. Exp. Ther., 227, 545-550.
42. Lasker,J.M., Sivarajah,K., Mason,R.P., Kalyanaraman,B., Abou-Donia,M.B. and Eling,T.E. (1981) A free radical mechanism of prostaglandin synthase-dependent aminopyrine demethylation. J. Biol. Chem., 256, 7764-7767.
43. Wise,R.W., Zenser,T.V. and Davis,B.B. (1985) Prostaglandin H synthase oxidation of benzidine and o-dianisidine: Reduction and conjugation of activated amines by thiols. Carcinogenesis, 6, 579-583.
44. Wise,R.W., Zenser,T.V. and Davis,B.B. (1984) Characterization of benzidinediimine: a product of peroxidase metabolism of benzidine. Carcinogenesis, 5, 1499-1503.
45. Mottley,C. and Mason,R.P. (1989) Nitroxide radical adducts in biology: Chemistry, applications, and pitfalls. Biol. Magnet. Reson., 8, 489-546.
46. Markey,C.M., Alward,A., Weller,P.E. and Marnett,L.J. (1987) Quantitative studies of hydroperoxide reduction by prostaglandin H synthase. J. Biol. Chem., 262, 6266-6279.
47. Cohen,S.M., Zenser,T.V., Murasaki,G., Fukushima,S., Mattammal,M.B., Rapp,N.S. and Davis,B.B. (1981) Aspirin inhibition of N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase. Cancer Res., 41, 3355-3359.
48. Sakata,T., Hasegawa,R., Johansson,S.L., Zenser,T.V. and Cohen,S.M. (1986) Inhibition by aspirin of N-(4-(5-nitro-2-furyl)-2-thiazolyl)-formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats. Cancer Res., 46, 3903-3906.
49. Potter,D.W. and Hinson,J.A. (1987) The 1- and 2-electron oxidation of acetaminophen catalyzed by prostaglandin H synthase. J. Biol. Chem., 262, 974-980.
50. Potter,D.W., Miller,D.W. and Hinson,J.A. (1986) Horseradish peroxidase-catalyzed oxidation of acetaminophen to intermediates that form polymers or conjugate with glutathione. Mol. Pharmacol., 29, 155-162.
51. Boyd,J.A., Harvan,D.J. and Eling,T.E. (1983) The oxidation of 2-aminofluorene by prostaglandin endoperoxide synthetase. J. Biol. Chem., 258, 8246-8254.
52. Kraemer,S.A., Meade,E.A. and DeWitt,D.L. (1992) Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5′-flanking regulatory sequences. Arch. Biochem. Biophys., 293, 391-400.
53. Kujubu,D.A. and Hershman,H.R. (1992) Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. J. Biol. Chem., 267, 7991-7994.
54. Morita,I., Schindler,M., Regier,M.K., Otto,J.C., Hori,T., DeWitt,D.L. and Smith,W.L. (1995) Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J. Biol. Chem., 270, 10902-10908.
55. Hershman,H.R. (1991) Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem., 60, 281-319.
56. Riese,J., Hoff,T., Nordhoff,A., DeWitt,D.L., Resch,K. and Kaever,V. (1994) Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation. J. Leukocyte Biol., 55, 476-482.
57. Kraemer,S.A., Arthur,K.A., Denison,M.S., Smith,W.L. and DeWitt,D.L. (1996) Regulation of prostaglandin endoperoxide H synthase-2 expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch. Biochem. Biophys., 330, 319-328.
58. Zenser,T.V., Lakshmi,V.M., Rustan,T.D., Doll,M.A., Deitz,A.C., Davis,B.B. and Hein,D.W. (1996) Human N-acetylation of benzidine: Role of NAT1 and NAT2. Cancer Res., 56, 3941-3947.
59. Babu,S.R., Lakshmi,V.M., Hsu,F.F., Kane,K.E.,III, Zenser,T.V. and Davis,B.B. (1993) N-Acetylbenzidine-N′-glucuronidation by human, dog, and rat liver. Carcinogenesis, 14, 2605-2611.
60. Babu,S.R., Lakshmi,V.M., Zenser,T.V. and Davis,B.B. (1994) Glucuronidation of N-acetylbenzidine by human liver. Drug Metab. Dispos., 22, 922-927.
61. Rothman,N., Talaska,G., Hayes,R., Bhatnagar,V., Bell,D., Lakshmi,V., Kashyap,S., Dosemeci,M., Kashyap,R., Hsu,F., Jaeger,M., Hirvonen,A., Parikh,D., Davis,B. and Zenser,T. (1997) Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers. Cancer Epidemiol. Biomarkers Prev., 6, 1039-1042.
62. Zhou,Q., Talaska,G., Jaeger,M., Bhatnagar,V.K., Hayes,R.B., Zenser,T.V., Kashyap,S.K., Lakshmi,V.M., Kashyap,R., Dosemeci,M., Hsu,F.F., Parikh,D.J., Davis,B. and Rothman,N. (1997) Benzidine-DNA adduct levels in human peripheral white blood cells significantly correlate with levels in exfoliated urothelial cells. Mutat. Res., 393, 199-205.